GeneXpert—A Game-Changer for Tuberculosis Control?
2011

GeneXpert—A Game-Changer for Tuberculosis Control?

publication Evidence: moderate

Author Information

Author(s): Carlton A. Evans

Primary Institution: Universidad Peruana Cayetano Heredia

Hypothesis

Is the new tuberculosis diagnostic test, GeneXpert, the solution for TB control that it's said to be?

Conclusion

The GeneXpert MTB/RIF test has the potential to improve TB diagnosis and drug resistance testing, but its impact is limited by cost and the need for confirmatory testing.

Supporting Evidence

  • The GeneXpert test can detect TB and drug resistance in less than two hours.
  • Traditional smear microscopy misses a significant number of TB cases.
  • The GeneXpert test is feasible for use in peripheral labs and clinics.

Takeaway

The GeneXpert test can help find tuberculosis faster and check for drug resistance, but it might be too expensive for many people who need it.

Methodology

This is a perspective article discussing the implications of the GeneXpert MTB/RIF test based on recent studies.

Limitations

The test has limitations such as high costs, the need for electricity, and potential inaccuracies in drug resistance testing.

Digital Object Identifier (DOI)

10.1371/journal.pmed.1001064

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication